2026年11月2日星期一
M
Atlante Universale
Notizie flash globali
Pakistan refineries report 1,860% jump in profit amid war windfall— 日经 Nikkei AsiaAfter US midterms, democracy will face test of ability to self-correct— 日经 Nikkei AsiaThai reformists became too technocratic, party ex-leader Pita says— 日经 Nikkei AsiaJapan bamboo chopsticks catch on in South Korea— 日经 Nikkei AsiaOn India's east coast, tidepooling inspires marine conservation— 日经 Nikkei AsiaChina mega complex in Dalian puts spotlight on investment push— 日经 Nikkei AsiaTime for Japan to develop people who can sell content— 日经 Nikkei AsiaYen bond offerings hit record $16bn as AI funding race reaches Japan— 日经 Nikkei AsiaPakistan refineries report 1,860% jump in profit amid war windfall— 日经 Nikkei AsiaAfter US midterms, democracy will face test of ability to self-correct— 日经 Nikkei AsiaThai reformists became too technocratic, party ex-leader Pita says— 日经 Nikkei AsiaJapan bamboo chopsticks catch on in South Korea— 日经 Nikkei AsiaOn India's east coast, tidepooling inspires marine conservation— 日经 Nikkei AsiaChina mega complex in Dalian puts spotlight on investment push— 日经 Nikkei AsiaTime for Japan to develop people who can sell content— 日经 Nikkei AsiaYen bond offerings hit record $16bn as AI funding race reaches Japan— 日经 Nikkei Asia

Gilead-Backed Aspen Neuroscience Shares Dip 0.7% After IPO

Fonte Bloomberg 财经2 giorni fa
Sintesi del contenuto

Aspen Neuroscience Inc., a clinical-stage developer of cell therapies, fell 0.7% after raising about $140.6 million in a US initial public offering.

Questo sito fornisce solo titoli e indici di riepilogo; il contenuto completo e i diritti d'autore appartengono all'editore originale. Clicca sul link all'articolo originale per leggerlo.

Vai all'articolo originale
Canale di appartenenza
Economia e finanza
Regione di appartenenza
Americhe
Lingua originale
English
Numero di voce
business-4267d7ce

Comments 0 comments

No comments yet. Be the first.

Gilead-Backed Aspen Neuroscience Shares Dip 0.7% After IPO · Atlante Universale